Houot R, Bachy E, Cartron G, Gros FX, et al. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. Nat Med 2024 May 14. doi: 10.1038/s41591-024-03053.
PMID: 38745012